Advertisement

Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa

  • Neslihan AkdoganEmail author
  • Sibel Dogan
  • Pinar Incel-Uysal
  • Erdem Karabulut
  • Canan Topcuoglu
  • Basak Yalcin
  • Nilgun Atakan
Original Paper
  • 36 Downloads

Abstract

Hidradenitis suppurativa (HS) is a chronic disabling inflammatory disease of the follicular unit especially affecting apocrine gland-bearing skin areas. Little is known about systemic inflammatory complications of the disease. This study aimed to evaluate systemic inflammation in patients with HS by assessing serum amyloid A protein (SAA) and C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR) and to identify potential risk factors for HS. Forty-four patients (M/F: 28/16) and 44 age- and sex-matched controls (M/F: 28/16) were enrolled. Demographic, clinical, laboratory, and therapeutic data, including smoking status, body mass index (BMI), waist circumference (WC), serum fasting lipid profile, fasting blood glucose, SAA, and CRP levels, and ESR were assessed. Associations were investigated by univariate and multivariate analyses. Patients with HS showed significantly higher levels of pack-years of cigarette smoking, weight, BMI, and WC (P = 0.01, P < 0.001, P = 0.001) and elevated SAA and CRP levels and ESR (P = 0.008, P = 0.01 and P < 0.001). SAA and CRP levels and ESR were significantly associated with Hurley staging in patients with HS (P = 0.03, P = 0.003, P = 0.02). Multivariate logistic regression analysis revealed that each unit increase in the ESR increased the HS risk by 1.08-fold (95% CI 1.02–1.13). HS is significantly associated with SAA, CRP, and ESR. Among these inflammatory parameters, ESR was an independent risk factor for HS. We recommend assessment of SAA, CRP, and ESR as biomarkers that reflect the disease severity in HS patients likely to develop complications.

Keywords

Hidradenitis suppurativa Serum amyloid A C-reactive protein Erythrocyte sedimentation rate 

Abbreviations

HS

Hidradenitis suppurativa

CRP

C-reactive protein

ESR

Erythrocyte sedimentation rate

BMI

Body mass index

WC

Waist circumference

AA

Amyloid A

SBP

Systolic blood pressure

DBP

Diastolic blood pressure

SLP

Serum lipid profile

TC

Total cholesterol

HDL-C

High-density lipoprotein cholesterol

LDL-C

Low-density lipoprotein cholesterol

VLDL-C

Very low-density lipoprotein cholesterol

TG

Triglycerides

FBG

Fasting blood glucose

FMF

Familial Mediterranean fever

Notes

Acknowledgements

We kindly thank Hacettepe University editing service for meticulous editing of the manuscript.

Funding

This work was supported by Turkish Dermatology Society on January 24, 2019 (Grant number 2019-10).

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to declare.

Ethical approval

The study protocol was approved by the Medical Ethics Committee of Ankara Numune Training and Research Hospital (code E-18-2316, December 15, 2018). All study procedures were done in accordance with the ethical principles of the 1964 Declaration of Helsinki, and all the participants provided written informed consent.

References

  1. 1.
    Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GB (2015) Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 231(2):184–190CrossRefGoogle Scholar
  2. 2.
    Titze J, Schneider M, Krause H, Jacobi J, Stolte M, Linke RP, Rupprecht HD (2003) Diarrhea, nephrotic syndrome and hidradenitis suppurativa: an unusual case. Nephrol Dial Transplant 18(1):192–194CrossRefGoogle Scholar
  3. 3.
    Utrera-Busquets M, Romero-Mate A, Castano A, Alegre L, García-Donoso C, Borbujo J (2016) Severe hidradenitis suppurativa complicated by renal AA amyloidosis. Clin Exp Dermatol 41(3):287–289CrossRefGoogle Scholar
  4. 4.
    Schandorff KD, Miller IM, Krustrup D, Jemec GB, Marckmann P (2016) Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa. Clin Nephrol 86(1):51–54CrossRefGoogle Scholar
  5. 5.
    Ozer I, Karacin C, Adisen E, Guz G, Ali Gürer M (2017) Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: treatment with infliximab. Dermatol Ther 30(2):e12445CrossRefGoogle Scholar
  6. 6.
    Girouard SD, Falk RH, Rennke HG, Merola JF (2012) Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J 18(1):2PubMedGoogle Scholar
  7. 7.
    World Health Organization (2008) Waist circumference and waist-hip ratio: report of a WHO expert consultation. http://www.who.int/iris/handle/10665/44583. Accessed Dec 2008
  8. 8.
    Kochi S, Esaki M, Kurahara K (2018) Secondary gastrointestinal amyloid A amyloidosis possibly caused by hidradenitis suppurativa. Dig Endosc 30(5):681CrossRefGoogle Scholar
  9. 9.
    Yu N, Zhang S, Lu J, Li Y, Yi X, Tang L, Su L, Ding Y (2017) Serum amyloid A, an acute phase protein, stimulates proliferative and proinflammatory responses of keratinocytes. Cell Prolif 50(3):1–10CrossRefGoogle Scholar
  10. 10.
    Eklund KK, Niemi K, Kovanen PT (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32(4):335–348CrossRefGoogle Scholar
  11. 11.
    Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356(23):2361–2371CrossRefGoogle Scholar
  12. 12.
    Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314(16):1001–1005CrossRefGoogle Scholar
  13. 13.
    Pascual JC, Gonzalez I, Corona D, Hispan P, Ramos JM, Sánchez-Paya J, Jemec GB (2017) Assessment of subclinical atherosclerosis in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 31(7):1229–1238CrossRefGoogle Scholar
  14. 14.
    Akdogan N, Alli N, Uysal PI, Topcuoglu C, Candar T, Turhan T (2018) Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study. Arch Dermatol Res 310(10):785–793CrossRefGoogle Scholar
  15. 15.
    Jimenez-Gallo D, de la Varga-Martinez R, Ossorio-Garcia L, Albarran-Planelles C, Rodríguez C, Linares-Barrios M (2017) The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa. Mediat Inflamm 2017:2450401CrossRefGoogle Scholar
  16. 16.
    Prens E, Deckers I (2015) Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol 73(5 Suppl 1):S8–S11CrossRefGoogle Scholar
  17. 17.
    Hessam S, Sand M, Gambichler T, Bechara FG (2015) Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol 73(6):998–1005CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Dermatology and Venereology, School of MedicineHacettepe UniversityAnkaraTurkey
  2. 2.Department of Dermatology and Venereology, Ankara Numune Training and Research HospitalUniversity of Health SciencesAnkaraTurkey
  3. 3.Department of Biostatistics, School of MedicineHacettepe UniversityAnkaraTurkey
  4. 4.Department of Medical Biochemistry, Ankara Numune Training and Research HospitalUniversity of Health SciencesAnkaraTurkey

Personalised recommendations